Epigen Intim, 0.1% spray 60 ml

Epigen Intimate Spray – local antiviral and immunostimulating therapeutic and prophylactic agent based on activated glycyrrhizic acid derived from licorice root extract. Spray Epigen Intim helps eliminate discomfort, itching and burning in the intimate area, has antiviral action by inhibiting the reproduction of viruses and prevent their penetration into the cells. Produced by order of Chemigroup France S.A. (France) for LLC “INVAR” (Russia).

Active ingredient

Ammonium Glycyrrhizinate

Composition

Active ingredient:

activated glycyrrhizic acid 1 mg.

Auxiliary substances:

malic acid;

fumaric acid;

ascorbic acid;
<

folic acid;

propylene glycol;

twin 80 (polysorbate 80);

purified water.

Directions for use

Externally, intravaginally and intraurethrally. Shake the balloon before use. Keep the can in an upright position during use.

When used topically

The product is applied to the affected area from a distance of 4-5 cm using 1-2 pushes of the valve, which is the optimal therapeutic dose.

For intravaginal use

The nozzle provided should be used. Remove the valve from the spray bottle and put the valve on the nozzle. The spray head is then inserted into the vagina with the patient supine and the product is injected one to two squeezes on the spray head valve. After application the patient should be in the supine position for 5-10 minutes.

In men’s use

In addition to external application, the product is injected into the external orifice of the urethra with 1-2 squeezes of the sprayer valve.

In case of herpesvirus type I infection, shingles

Epigen Intimate is applied 6 times a day to the lesion for 5 days. If the disease persists, treatment is prolonged until symptoms have completely disappeared.

In case of herpesvirus type II infection (genital herpes), cytomegalovirus infection

It is recommended 5 times a day for 14 days topically and intravaginally, after relapse – topically and intravaginally 3 times a day for 10 days.

To prevent relapses of genital herpes and cytomegalovirus infection

To use topically and intravaginally from 18-20 days of the menstrual cycle until the end of menstruation 2 times a day in the morning and evening.

In case of papillomavirus infection the drug is recommended to be used

Before removal of condylomata 3 times a day for the period of etiotropic therapy; against the background of destruction – 5 times a day for 10 days or more until healing; for prevention of immediate recurrence – 3 times a day for 1 month.

To prevent the progression of papillomavirus infection

It is recommended to use the drug before and after sexual intercourse, as well as in the occurrence of triggering factors: stress, overexertion, respiratory viral infections, microflora disorders, taking antibiotics, cytostatics – 3 times/day intravaginally and externally for the duration of the triggering factors.

In case of nonspecific vulvovaginitis, bacterial vaginosis and candida vulvovaginitis

The drug is recommended to be used intravaginally 3-4 times a day for 7-10 days. If necessary the course of treatment should be repeated after 10 days. If there are provoking factors (respiratory viral infections, taking antibiotics, cytostatics) the drug is prescribed 3 times a day intravaginally and externally for the duration of exposure to provoking factors.

In case of genital discomfort accompanied by itching, burning, and dryness of the mucous membranes (including ovarian insufficiency and after sexual intercourse)

The drug is used 2 times a day (morning and evening) for 2-3 weeks. In order to prevent a state of discomfort, use regularly after sexual intercourse.

As a prophylactic antiviral agent

The drug is recommended to use before and after sexual intercourse.

Special Instructions

The nozzle is washed with soap and boiled water and stored in the polyethylene package provided. The nozzle is designed to irrigate the cervix and vaginal walls evenly.

When used in a hospital setting, intravaginal irrigation of preparations in mirrors can be performed without the nozzle.

There is no need to pre-rinse the affected area before using the medication to be effective.

If signs of intolerance occur, the use of the product should be discontinued.

The drug is approved for use throughout pregnancy and lactation.

Possible:

Individual intolerance to the components of the drug.

Rarely: local allergic reactions, including contact dermatitis.

I have not found any interaction with the main groups of drugs used for the complex treatment of viral diseases (analgesics and antiseptics, anti-inflammatory and analgesic agents).

The synergism was found in simultaneous use of glycyrrhizic acid and other antiviral drugs, in particular acyclovir derivatives, iodouridine, interferon and other immunomodulators.

.

Contraindications

High sensitivity to the components of Epigen Intim.

Assignments

• Treatment of viral infection caused by human papillomavirus, including. asymptomatic isolation of human papillomavirus of high oncogenic risk, as part of combined and complex therapy;
• treatment of viral infection caused by herpes simplex virus types 1 and 2 as part of complex therapy;
• treatment of viral infection caused by Varicella Zoster virus (shingles) in complex therapy;
• treatment of viral infection caused by cytomegalovirus in complex therapy;
• prevention of relapse prevention of viral infections caused by herpes simplex virus types 1 and 2, Varicella Zoster virus, human papillomavirus, cytomegalovirus;
• prevention of acute conchial infections as part of complex therapyPrevention and treatment of acute condyloma and cervical pathology caused by HPV, CMV;
• prevention and treatment of conditions accompanied by a decrease in local immunity, including nonspecific vulva.
• prevention and treatment of conditions accompanied by a decrease in local immunity, including nonspecific vulvovaginitis, candidiasis vulvovaginitis and bacterial vaginosis in combination therapy.
• Events of discomfort in the genital area, accompanied by itching, burning and dry mucous membranes, with insufficient ovarian function.

.

Similarities

Reglisam